Back to today’s briefing

Story perspectives

Glenmark Recalls 11,100 Ziac Tablets Over Contamination Concerns

12/11/2025

34 5 Full Breakdown

Summary

Story summary

Glenmark Pharmaceuticals Inc. recalled more than 11,100 bottles of Ziac tablets due to potential cross-contamination with ezetimibe.
The U.S. Food and Drug Administration announced the recall on December 1 and classified it as Class III.
The affected tablets come in 2.5 mg and 6.25 mg doses, with lot numbers and expiration dates from November 2025 to May 2026.
The FDA has not issued patient guidance for this recall.

1 of 1

Story summary

Glenmark Pharmaceuticals Inc. recalled more than 11,100 bottles of Ziac tablets due to potential cross-contamination with ezetimibe.
The U.S. Food and Drug Administration announced the recall on December 1 and classified it as Class III.
The affected tablets come in 2.5 mg and 6.25 mg doses, with lot numbers and expiration dates from November 2025 to May 2026.
The FDA has not issued patient guidance for this recall.